YANKCOM Partnership’s Pfizer PFE Stock Holding History

YANKCOM Partnership’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-717	Closed	-$20.1K	–	363
2026 Q1	$20.1K	Sell	717 -391	-35%	-$10.4K	0.01%	227
2025 Q4	$27.6K	Buy	+1,108	New	+$27.9K	0.01%	221

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

YANKCOM Partnership's PFE Position: Q2 2026 in Review

YANKCOM Partnership sold out of Pfizer (PFE) in Q2 2026, closing a stake of 717 shares — an estimated $20.1K sold.

YANKCOM Partnership first reported a position in PFE in Q4 2025 and held it in 2 quarters. The position peaked at $27.6K in Q4 2025. 1,776 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

YANKCOM Partnership reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
YANKCOM Partnership sold 717 Pfizer shares in Q2 2026, an estimated $20.1K.
YANKCOM Partnership first reported a position in Pfizer in Q4 2025 and held it in 2 quarters.
YANKCOM Partnership's Pfizer position peaked at $27.6K in Q4 2025.
1,776 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on YANKCOM Partnership's 13F filing for Q2 2026, filed 21 Jul 2026.